News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Icro Meattini: Technical innovation in breast cancer – optimising the workflow
Icro Meattini/X
May 5, 2025, 02:16

Icro Meattini: Technical innovation in breast cancer – optimising the workflow

Icro Meattini, Associate Professor of Radiation Oncology at the University of Florence, shared a post on X:

“Technical innovation in breast cancer – optimising the workflow. Exciting session ESTRO25 showing years of technical implementation leading to significant clinical improvement.”

Icro Meattini

More posts featuring ESTRO.

cancer ESTRO ESTRO25 Icro Meattini OncoDaily Oncology
Special Coverage
Blog
May 21, 2025, 21:13
2025 Chinese Congress on Holistic Integrative Oncology (CCHIO)
Insight
May 21, 2025, 19:15
Haydeé Verduzco-Aguirre shared study on 20-year breast cancer trends and treatment gaps in São Paulo
Insight
May 21, 2025, 19:10
Samuel Hume: Top 5 advances in medicine this week
Insight
May 21, 2025, 19:04
FDA and HHS announced next steps in Operation Stork Speed for infant formula nutrition standards
Insight
May 21, 2025, 18:49
Joe Y. Chang on upcoming PTCOG 63: IMRT vs IMPT Phase III trials
Blog
May 21, 2025, 18:11
Poland’s Cancer Landscape at Cancer Mission Fair - European Cancer Organisation
Insight
May 21, 2025, 18:05
Goutham Sunny on KRAS G12C inhibition in non-small cell lung cancer
Blog
May 21, 2025, 18:02
Tackling Information Overload in Cancer Research - Train at NCI
Societies
May 21, 2025, 17:54
Patrick Hwu: Kicked off the 2025 Scientific Symposium at Moffitt Cancer Center
Blog
May 21, 2025, 17:54
Applications are Open for the Basic Principles in Oncology Course - European School of Oncology
Career
May 21, 2025, 17:46
Sharon Kapambwe Has Been Appointed as Technical Officer for Cancer Control at WHO Uzbekistan
Opinion
May 21, 2025, 17:41
Bishal Gyawali addressed G7 cancer drug approval claims about Canada with the Lancet Oncology Study